+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Antithrombotic Drugs Market 2019-2027

  • ID: 4773768
  • Report
  • Region: Global
  • 130 pages
  • Triton Market Research
1 of 3

FEATURED COMPANIES

  • Abbott Laboratories
  • Baxter International
  • Boehringer Ingelheim Gmbh
  • Csl Behring
  • Eli Lilly And Company
  • Johnson & Johnson
  • MORE
Market Outlook
The antithrombotic drugs market is projected to progress at 6.61% of CAGR over the forecast period 2019-2027. The factors responsible for the growth of antithrombotic drugs market globally are the increasing prevalence of chronic diseases, rising geriatric population, increase in the genetic diseases, lack of physical activity, growing awareness among patients about potentially fatal diseases, changing lifestyles and increasing hypertension. The major factors restricting the market growth are the increasing geriatric population and the high cost of NOACs.

The increasing pervasiveness of coagulation diseases and the rising healthcare businesses are the key opportunities for the antithrombotic drugs market to evolve over the forecasting years. However, the scarcity of NOACs medicines and lapse of licenses are expected to create a challenge to the growth of the market.

Regional Outlook
The global antithrombotic drugs market report covers regions such as North America, Europe, Asia-Pacific, Latin America and the Middle East & Africa. The Asia-Pacific region is anticipated to hold the highest CAGR over the forecast period of 2019-2027. The main reason attributed to the rapid growth of the market is the increasing demand for antithrombotic drugs amid the population.

Asia-Pacific is expected to increase at a rapid pace when compared with Europe and the Americas owing to the low awareness in these regions. With the rising cognizance and improvements in the healthcare infrastructure, the patient pool is expected to increase in the APAC region. For instance, the healthcare organizations are implementing guidelines to endorse the use of certain drugs for the prevention and treatment of anti-coagulant disorders. The relatively developed countries within Asia-Pacific prefer the factor Xa inhibitors over conventional heparins.

Competitive Outlook
Some of the dominating players in the market are Bayer, GlaxoSmithKline, Eli Lilly and Company, Baxter International, Boehringer Ingelheim GmbH, Abbott Laboratories, Merck & Co., Bristol-Myers Squibb Co., Daiichi Sankyo Co., Ltd., Novartis, Pfizer, F. Hoffmann-La Roche, Ltd., Bayer, CSL Behring, Armetheon, Inc., Sanofi and Johnson & Johnson.

CSL Behring is a biotherapeutics company engaged in the R&D and manufacturing of plasma protein and marketing of protein-based therapies. These products are used for coagulation disorders in critical care settings. They are also used to prevent hemolytic disease in newborns. The biotherapies can be used as treatments for hemophilia, Von Willebrand’s disease, immune deficiencies and inherited respiratory disease. The products offered by the company can also be used to treat sepsis wound healing during cardiac surgery and severe burns.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott Laboratories
  • Baxter International
  • Boehringer Ingelheim Gmbh
  • Csl Behring
  • Eli Lilly And Company
  • Johnson & Johnson
  • MORE
1. Antithrombotic Drugs Market - Summary

2. Industry Outlook
2.1. Market Definition
2.2. Porter's Five Forces Outlook
2.2.1. Threat Of New Entrants
2.2.2. Threat Of Substitutes
2.2.3. Bargaining Power Of Buyers
2.2.4. Bargaining Power Of Suppliers
2.2.5. Threat Of Rivalry
2.3. Key Insights
2.4. Market Outlook
2.5. Patent Outlook
2.6. Key Drugs In The Antithrombotic Drugs Market
2.7. Key Buying Outlook
2.8. Market Drivers
2.8.1. Increasing Adoption Rates Of Noacs
2.8.2. Government Initiatives
2.8.3. Increase In Hip And Knee Replacement Surgeries
2.9. Market Restraints
2.9.1. Rising Aging Population
2.9.2. Higher Cost Of Noacs
2.10. Market Opportunities
2.10.1. Increasing Healthcare Industries
2.10.2. Increasing Pervasiveness Of Coagulation Maladies
2.11. Market Challenges
2.11.1. Dearth Of Noacs Remedies In The Market
2.11.2. Expiration Of Patents

3. Antithrombotic Drugs Market Outlook - By Types
3.1. Anticoagulants
3.1.1. Anticoagulants By Drugs Type
3.1.1.1. Low Molecular Weight Heparin
3.1.1.2. Oral Anticoagulants (Vitamin K Antagonists)
3.1.2. Anticoagulants By Rapid Onset Anticoagulant (Roa)
3.1.2.1. Oral
3.1.2.2. Injectables
3.1.3. Anticoagulants By Drug Class
3.1.3.1. Factor Xa
3.1.3.2. Dtis
3.1.3.3. Heparin
3.1.3.4. Vitamin K Antagonists
3.1.4. Anticoagulants By Applications
3.1.4.1. Pe
3.1.4.2. Dvt
3.1.4.3. Af
3.1.4.4. Other Anticoagulants Applications
3.2. Antiplatelets
3.2.1. Oral Antiplatelets
3.2.2. Iv Antiplatelets
3.3. Thrombin Inhibitors
3.3.1. Direct Factor Xa Inhibitors
3.3.2. Direct Thrombin Inhibitors
3.3.3. Thrombolytic Agents

4. Antithrombotic Drugs Market - Regional Outlook
4.1. North America
4.1.1. Country Analysis
4.1.1.1. The United States
4.1.1.2. Canada
4.2. Europe
4.2.1. Country Analysis
4.2.1.1. The United Kingdom
4.2.1.2. France
4.2.1.3. Germany
4.2.1.4. Spain
4.2.1.5. Italy
4.2.1.6. Russia
4.2.1.7. Rest Of Europe
4.3. Asia-Pacific
4.3.1. Country Analysis
4.3.1.1. India
4.3.1.2. China
4.3.1.3. Japan
4.3.1.4. South Korea
4.3.1.5. ASEAN Countries
4.3.1.6. Australia & New Zealand
4.3.1.7. Rest Of Apac
4.4. Middle East And Africa (Mea)
4.4.1. Country Analysis
4.4.1.1. Saudi Arabia
4.4.1.2. Turkey
4.4.1.3. United Arab Emirates
4.4.1.4. South Africa
4.4.1.5. Rest Of Middle East And Africa
4.5. Latin America
4.5.1. Country Analysis
4.5.1.1. Brazil
4.5.1.2. Mexico
4.5.1.3. Rest Of Latin America

5. Competitive Landscape
5.1. Abbott Laboratories
5.2. Armetheon, Inc.
5.3. Baxter International
5.4. Bayer
5.5. Boehringer Ingelheim GmbH
5.6. Bristol-Myers Squibb, Co.
5.7. Csl Behring
5.8. Daiichi Sankyo Co., Ltd.
5.9. Eli Lilly And Company
5.10. F. Hoffmann-La Roche, Ltd.
5.11. Glaxosmithkline
5.12. Johnson & Johnson
5.13. Merck & Co.
5.14. Novartis
5.15. Pfizer
5.16. Sanofi

6. Research & Methodology
6.1. Research Scope
6.2. Sources Of Data
6.3. Research Methodology

List of Tables
Table 1: Global Antithrombotic Drugs Market, By Region, 2019-2027 ($ Million)
Table 2: Numbers Of Patents On Antithrombotics And Anticoagulants, By Various Companies, 2011-2016
Table 3: Numbers Of Patents On Anticoagulants, By Various Companies, 2011-2016
Table 4: Indian Government Initiatives In The Healthcare Sector
Table 5: Global Antithrombotic Drugs Market, By Types, 2019-2027 ($ Million)
Table 6: Global Antithrombotic Drugs Market In Anticoagulants, By Drugs Type, 2019-2027 ($ Million)
Table 7: Lovenox Drug Brand
Table 8: Global Antithrombotic Drugs Market In Anticoagulants, By Roa, 2019-2027 ($ Million)
Table 9: Global Antithrombotic Drugs Market In Anticoagulants, By Drug Class, 2019-2027 ($ Million)
Table 10: Global Antithrombotic Drugs Market In Anticoagulants, By Applications, 2019-2027 ($ Million)
Table 11: Global Antithrombotic Drugs Market In Antiplatelets, By Types, 2019-2027 ($ Million)
Table 12: Global Antithrombotic Drugs Market In Thrombin Inhibitors, By Types, 2019-2027 ($ Million)
Table 13: North America Antithrombotic Drugs Market, By Countries, 2019-2027 ($ Million)
Table 14: Europe Antithrombotic Drugs Market, By Countries, 2019-2027 ($ Million)
Table 15: Asia-Pacific Antithrombotic Drugs Market, By Countries, 2019-2027 ($ Million)
Table 16: Middle East And Africa Antithrombotic Drugs Market, By Countries, 2019-2027 ($ Million)
Table 17: Latin America Antithrombotic Drugs Market, By Countries, 2019-2027 ($ Million)

List of Figures
Figure 1: Global Antithrombotic Drugs Market By Region 2019-2027 ($ Million)
Figure 2: Rapidly Growing Industry In The World (%)
Figure 3: Global Antithrombotic Drugs Market In Anticoagulants 2019-2027 ($ Million)
Figure 4: Blood Coagulation Process
Figure 5: Global Anticoagulants Market In Low Molecular Weight Heparin 2019-2027 ($ Million)
Figure 6: Global Anticoagulants Market In Low Oral Anticoagulants (Vitamin K Antagonists) 2019-2027 ($ Million)
Figure 7: Global Anticoagulants Market In Oral 2019-2027 ($ Million)
Figure 8: Global Anticoagulants Market In Injectables 2019-2027 ($ Million)
Figure 9: Global Anticoagulants Market In Factor Xa 2019-2027 ($ Million)
Figure 10: Global Anticoagulants Market In Dtis 2019-2027 ($ Million)
Figure 11: Global Anticoagulants Market In Heparin 2019-2027 ($ Million)
Figure 12: Global Anticoagulants Market In Vitamin K Antagonists 2019-2027 ($ Million)
Figure 13: Global Anticoagulants Market In Pe 2019-2027 ($ Million)
Figure 14: Global Anticoagulants Market In Dvt 2019-2027 ($ Million)
Figure 15: Global Anticoagulants Market In Af 2019-2027 ($ Million)
Figure 16: Global Anticoagulants Market In Other Anticoagulants Applications 2019-2027 ($ Million)
Figure 17: Global Antithrombotic Drugs Market In Antiplatelets 2019-2027 ($ Million)
Figure 18: Global Antiplatelets Market In Oral Antiplatelets 2019-2027 ($ Million)
Figure 19: Global Antiplatelets Market In Iv Antiplatelets 2019-2027 ($ Million)
Figure 20: Global Antithrombotic Drugs Market In Thrombin Inhibitors 2019-2027 ($ Million)
Figure 21: Global Thrombin Inhibitors Market In Direct Factor Xa Inhibitors 2019-2027 ($ Million)
Figure 22: Global Thrombin Inhibitors Market In Direct Thrombin Inhibitors 2019-2027 ($ Million)
Figure 23: Global Thrombin Inhibitors Market In Thrombolytic Agents 2019-2027 ($ Million)
Figure 24: Global Antithrombotic Drugs Market By Region 2019-2027 ($ Million)
Figure 25: The United States Antithrombotic Drugs Market 2019-2027 ($ Million)
Figure 26: Canada Antithrombotic Drugs Market 2019-2027 ($ Million)
Figure 27: The United Kingdom Antithrombotic Drugs Market 2019-2027 ($ Million)
Figure 28: France Antithrombotic Drugs Market 2019-2027 ($ Million)
Figure 29: Germany Antithrombotic Drugs Market 2019-2027 ($ Million)
Figure 30: Spain Antithrombotic Drugs Market 2019-2027 ($ Million)
Figure 31: Italy Antithrombotic Drugs Market 2019-2027 ($ Million)
Figure 32: Russia Antithrombotic Drugs Market 2019-2027 ($ Million)
Figure 33: Rest Of Europe Antithrombotic Drugs Market 2019-2027 ($ Million)
Figure 34: India Antithrombotic Drugs Market 2019-2027 ($ Million)
Figure 35: China Antithrombotic Drugs Market 2019-2027 ($ Million)
Figure 36: Japan Antithrombotic Drugs Market 2019-2027 ($ Million)
Figure 37: South Korea Antithrombotic Drugs Market 2019-2027 ($ Million)
Figure 38: ASEAN Countries Antithrombotic Drugs Market 2019-2027 ($ Million)
Figure 39: Australia And New Zealand Antithrombotic Drugs Market 2019-2027 ($ Million)
Figure 40: Rest Of Apac Antithrombotic Drugs Market 2019-2027 ($ Million)
Figure 41: Saudi Arabia Antithrombotic Drugs Market 2019-2027 ($ Million)
Figure 42: Turkey Antithrombotic Drugs Market 2019-2027 ($ Million)
Figure 43: United Arab Emirates Antithrombotic Drugs Market 2019-2027 ($ Million)
Figure 44: South Africa Antithrombotic Drugs Market 2019-2027 ($ Million)
Figure 45: Rest Of Middle East And Africa Antithrombotic Drugs Market 2019-2027 ($ Million)
Figure 46: Brazil Antithrombotic Drugs Market 2019-2027 ($ Million)
Figure 47: Mexico Antithrombotic Drugs Market 2019-2027 ($ Million)
Figure 48: Rest Of Latin America Antithrombotic Drugs Market 2019-2027 ($ Million)
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Abbott Laboratories
  • Armetheon, Inc.
  • Baxter International
  • Bayer
  • Boehringer Ingelheim Gmbh
  • Bristol-Myers Squibb, Co.
  • Csl Behring
  • Daiichi Sankyo Co., Ltd.
  • Eli Lilly And Company
  • F. Hoffmann-La Roche, Ltd.
  • Glaxosmithkline
  • Johnson & Johnson
  • Merck & Co.
  • Novartis
  • Pfizer
  • Sanofi
Note: Product cover images may vary from those shown
Adroll
adroll